|
1
|
Jeong SY, Kim HW, Lee SW, Ahn BC and Lee
J: Salivary gland function 5 years after radioactive iodine
ablation in patients with differentiated thyroid cancer: direct
comparison of pre- and postablation scintigraphies and their
relation to xerostomia symptoms. Thyroid. 23:609–616. 2013.
|
|
2
|
Siironen P, Hagstrom J, Maenpaa HO, et al:
Anaplastic and poorly differentiated thyroid carcinoma: therapeutic
strategies and treatment outcome of 52 consecutive patients.
Oncology. 79:400–408. 2010. View Article : Google Scholar
|
|
3
|
Sakorafas GH, Lappas C, Mastoraki A,
Kotsilianou O, Makras P and Safioleas M: Extensive and concurrent
infiltration of an ectopic intrathoracic thyroid and thyroid gland
by papillary thyroid cancer. Am Surg. 76:E152–E153. 2010.PubMed/NCBI
|
|
4
|
Darnell JE Jr: STATs and gene regulation.
Science. 277:1630–1635. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lu Y, Fukuyama S, Yoshida R, et al: Loss
of SOCS3 gene expression converts STAT3 function from
anti-apoptotic to pro-apoptotic. J Biol Chem. 281:36683–36690.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mora LB, Buettner R, Seigne J, et al:
Constitutive activation of Stat3 in human prostate tumors and cell
lines: direct inhibition of Stat3 signaling induces apoptosis of
prostate cancer cells. Cancer Res. 62:6659–6666. 2002.PubMed/NCBI
|
|
7
|
Li L and Shaw PE: Autocrine-mediated
activation of STAT3 correlates with cell proliferation in breast
carcinoma lines. J Biol Chem. 277:17397–17405. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Epling-Burnette PK, Liu JH,
Catlett-Falcone R, et al: Inhibition of STAT3 signaling leads to
apoptosis of leukemic large granular lymphocytes and decreased
Mcl-1 expression. J Clin Invest. 107:351–362. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Song L, Turkson J, Karras JG, Jove R and
Haura EB: Activation of Stat3 by receptor tyrosine kinases and
cytokines regulates survival in human non-small cell carcinoma
cells. Oncogene. 22:4150–4165. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kim EJ, Park JI and Nelkin BD: IFI16 is an
essential mediator of growth inhibition, but not differentiation,
induced by the leukemia inhibitory factor/JAK/STAT pathway in
medullary thyroid carcinoma cells. J Biol Chem. 280:4913–4920.
2005. View Article : Google Scholar
|
|
11
|
Grandis JR, Drenning SD, Zeng Q, et al:
Constitutive activation of Stat3 signaling abrogates apoptosis in
squamous cell carcinogenesis in vivo. Proc Natl Acad Sci
USA. 97:4227–4232. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gao L, Zhang L, Hu J, et al:
Down-regulation of signal transducer and activator of transcription
3 expression using vector-based small interfering RNAs suppresses
growth of human prostate tumor in vivo. Clin Cancer Res.
11:6333–6341. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ling X and Arlinghaus RB: Knockdown of
STAT3 expression by RNA interference inhibits the induction of
breast tumors in immunocompetent mice. Cancer Res. 65:2532–2536.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lee SO, Lou W, Qureshi KM, Mehraein-Ghomi
F, Trump DL and Gao AC: RNA interference targeting Stat3 inhibits
growth and induces apoptosis of human prostate cancer cells.
Prostate. 60:303–309. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Angell JE, Lindner DJ, Shapiro PS, Hofmann
ER and Kalvakolanu DV: Identification of GRIM-19, a novel cell
death-regulatory gene induced by the interferon-β and retinoic acid
combination, using a genetic approach. J Biol Chem.
275:33416–33426. 2000.PubMed/NCBI
|
|
16
|
Zhang L, Gao L, Li Y, et al: Effects of
plasmid-based Stat3-specific short hairpin RNA and GRIM-19 on PC-3M
tumor cell growth. Clin Cancer Res. 14:559–568. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Huang Y, Yang M, Yang H and Zeng Z:
Upregulation of the GRIM-19 gene suppresses invasion and metastasis
of human gastric cancer SGC-7901 cell line. Exp Cell Res.
316:2061–2070. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Huang G, Chen Y, Lu H and Cao X: Coupling
mitochondrial respiratory chain to cell death: an essential role of
mitochondrial complex I in the interferon-β and retinoic
acid-induced cancer cell death. Cell Death Differ. 14:327–337.
2007.PubMed/NCBI
|
|
19
|
Alchanati I, Nallar SC, Sun P, et al: A
proteomic analysis reveals the loss of expression of the cell death
regulatory gene GRIM-19 in human renal cell carcinomas. Oncogene.
25:7138–7147. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lufei C, Ma J, Huang G, et al: GRIM-19, a
death-regulatory gene product, suppresses Stat3 activity via
functional interaction. EMBO J. 22:1325–1335. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang J, Yang J, Roy SK, et al: The cell
death regulator GRIM-19 is an inhibitor of signal transducer and
activator of transcription 3. Proc Natl Acad Sci USA.
100:9342–9347. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nallar SC, Kalakonda S, Lindner DJ, et al:
Tumor-derived mutations in the gene associated with retinoid
interferon-induced mortality (GRIM-19) disrupt its anti-signal
transducer and activator of transcription 3 (STAT3) activity and
promote oncogenesis. J Biol Chem. 288:7930–7941. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kumar BN, Rajput S, Dey KK, et al:
Celecoxib alleviates tamoxifen-instigated angiogenic effects by
ROS-dependent VEGF/VEGFR2 autocrine signaling. BMC Cancer.
13:2732013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: the next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chau BN and Wang JY: Coordinated
regulation of life and death by RB. Nat Rev Cancer. 3:130–138.
2003. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Panguluri SK, Yeakel C and Kakar SS: PTTG:
an important target gene for ovarian cancer therapy. J Ovarian Res.
1:62008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Turkson J: STAT proteins as novel targets
for cancer drug discovery. Expert Opin Ther Targets. 8:409–422.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Masuda M, Suzui M, Yasumatu R, et al:
Constitutive activation of signal transducers and activators of
transcription 3 correlates with cyclin D1 overexpression and may
provide a novel prognostic marker in head and neck squamous cell
carcinoma. Cancer Res. 62:3351–3355. 2002.
|
|
29
|
Alas S and Bonavida B: Rituximab
inactivates signal transducer and activation of transcription 3
(STAT3) activity in B-non-Hodgkin’s lymphoma through inhibition of
the interleukin 10 autocrine/paracrine loop and results in
down-regulation of Bcl-2 and sensitization to cytotoxic drugs.
Cancer Res. 61:5137–5144. 2001.PubMed/NCBI
|
|
30
|
Aoki Y, Feldman GM and Tosato G:
Inhibition of STAT3 signaling induces apoptosis and decreases
survivin expression in primary effusion lymphoma. Blood.
101:1535–1542. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wei D, Le X, Zheng L, et al: Stat3
activation regulates the expression of vascular endothelial growth
factor and human pancreatic cancer angiogenesis and metastasis.
Oncogene. 22:319–329. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xie TX, Wei D, Liu M, et al: Stat3
activation regulates the expression of matrix metalloproteinase-2
and tumor invasion and metastasis. Oncogene. 23:3550–3560. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Elbashir SM, Harborth J, Weber K and
Tuschl T: Analysis of gene function in somatic mammalian cells
using small interfering RNAs. Methods. 26:199–213. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wen LJ, Gao LF, Jin CS, et al: Small
interfering RNA survivin and GRIM-19 co-expression salmonella
plasmid inhibited the growth of laryngeal cancer cells in vitro and
in vivo. Int J Clin Exp Pathol. 6:2071–2081. 2013.PubMed/NCBI
|
|
35
|
Farina AR, Tacconelli A, Vacca A, Maroder
M, Gulino A and Mackay AR: Transcriptional up-regulation of matrix
metalloproteinase-9 expression during spontaneous epithelial to
neuroblast phenotype conversion by SK-N-SH neuroblastoma cells,
involved in enhanced invasivity, depends upon GT-box and nuclear
factor kappaB elements. Cell Growth Differ. 10:353–367. 1999.
|
|
36
|
Bond M, Fabunmi RP, Baker AH and Newby AC:
Synergistic upregulation of metalloproteinase-9 by growth factors
and inflammatory cytokines: an absolute requirement for
transcription factor NF-κB. FEBS Lett. 435:29–34. 1998.PubMed/NCBI
|
|
37
|
Yang EV, Kim SJ, Donovan EL, et al:
Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human
melanoma tumor cell lines: implications for stress-related
enhancement of tumor progression. Brain Behav Immun. 23:267–275.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Braicu EI, Gasimli K, Richter R, et al:
Role of serum VEGFA, TIMP2, MMP2 and MMP9 in monitoring response to
adjuvant radiochemotherapy in patients with primary cervical cancer
- results of a companion protocol of the randomized NOGGO-AGO Phase
III Clinical Trial. Anticancer Res. 34:385–391. 2014.
|
|
39
|
Lai WW, Hsu SC, Chueh FS, et al: Quercetin
inhibits migration and invasion of SAS human oral cancer cells
through inhibition of NF-κB and matrix metalloproteinase-2/-9
signaling pathways. Anticancer Res. 33:1941–1950. 2013.PubMed/NCBI
|
